Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Respir J ; 37(4): 823-34, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20693251

ABSTRACT

The mechanism(s) involved in the development of pulmonary hypertension (PH) in COPD is still the object of investigation. Cigarette smoke (CS) may lead to remodelling of intrapulmonary vessels and dynamic changes in vascular function, at least in some smokers. A role for proteases in PH has been recently put forward. We investigated, in smoking mice, the role of protease-activated receptor (PAR)-2 in the pathogenesis of PH associated with emphysema. We demonstrated that CS exposure can modulate PAR-2 expression in mouse lung. Acute CS exposure induces in wildtype (WT) and in transgenic mice over-expressing PAR-2 (FVB(PAR-2-TgN)) a similar degree of neutrophil influx in bronchoalveolar lavage fluids. After chronic CS exposure WT and FVB(PAR-2-TgN) mice show emphysema, but only transgenic mice develop muscularisation of small intrapulmonary vessels that precedes the development of PH (~45% increase) and right ventricular hypertrophy. Smoking in FVB(PAR-2-TgN) mice results in an imbalance between vasoconstrictors (especially endothelin-1) and vasodilators (i.e. vascular endothelial growth factor, endothelial nitric oxide synthase and inducible nitric oxide synthase) and enhanced production of growth factors involved both in fibroblast-smooth muscle cell transaction (i.e. platelet-derived growth factor (PDGF) and transforming growth factor ß) and vascular cell proliferation (PDGF). PAR-2 signalling can influence the production and release of many factors, which may play a role in the development of PH in smokers.


Subject(s)
Hypertension, Pulmonary/etiology , Receptor, PAR-2/biosynthesis , Smoking/adverse effects , Animals , Apoptosis , Bronchoalveolar Lavage Fluid , Cell Proliferation , Disease Models, Animal , Gene Expression Regulation , Hypertension, Pulmonary/metabolism , Hypertrophy, Right Ventricular , Immunohistochemistry/methods , Lung/drug effects , Mice , Mice, Transgenic , RNA/metabolism , Signal Transduction
2.
Neuroscience ; 138(2): 487-99, 2006.
Article in English | MEDLINE | ID: mdl-16388914

ABSTRACT

To complete a series of studies on the expression of substance P and neurokinin receptors in mammalian retinas, we investigated the occurrence of these molecules in developing mouse retinas and in retinas of mice with genetic deletion of the neurokinin 1 receptor, the preferred substance P receptor. Using semi-quantitative reverse transcription-polymerase chain reaction, we measured detectable levels of the gamma isoform of preprotachykinin A (a substance P precursor) mRNA at postnatal day 4. Neurokinin 1 receptor and neurokinin 3 receptor mRNAs were also detected at postnatal day 4. While gamma preprotachykinin A and neurokinin 1 receptor mRNA levels significantly increased up to eye opening (postnatal day 11), neurokinin 3 receptor mRNA levels remained constant throughout development. Substance P, neurokinin 1 receptor and neurokinin 3 receptor immunoreactivities were present at postnatal day 5. Substance P was in amacrine cells, neurokinin 1 receptor in developing amacrine and bipolar cells and neurokinin 3 receptor in OFF-type cone bipolar cells. Interestingly, a transient increase in the density of neurokinin 1 receptor immunoreactive processes was observed at eye opening in lamina 3 of the inner plexiform layer, suggesting a role of substance P and neurokinin 1 receptor in this developmental phase. However, in neurokinin 1 receptor knockout retinas, besides a significant increase of the gamma preprotachykinin A mRNA levels, no major changes were detected: neurokinin 3 receptor mRNA levels as well as substance P and neurokinin 3 receptor immunostainings were similar to wild types. Together with previous studies, these observations indicate that there are major differences in neurokinin 1 receptor expression patterns among developing mammalian retinas. The observations in neurokinin 1 receptor knockout mice may not be applicable to rats or rabbits, and substance P and neurokinin 1 receptor may play different developmental roles in different species.


Subject(s)
Receptors, Neurokinin-1/deficiency , Receptors, Neurokinin-1/genetics , Receptors, Neurokinin-3/genetics , Retina/physiology , Substance P/genetics , Aging , Animals , Base Sequence , Cyclophilins/genetics , DNA Primers , Gene Expression Regulation, Developmental , Mice , Mice, Knockout , Peptidylprolyl Isomerase/genetics , RNA, Messenger/genetics , Retina/growth & development
3.
Eur Respir J ; 25(1): 15-22, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15640318

ABSTRACT

The development of cigarette smoke-induced pulmonary changes in C57 Bl/6J and DBA/2 mice was investigated. Both strains are sensitive to oxidants and C57Bl/6J mice are moderately deficient in serum alpha1-proteinase inhibitor. Following chronic exposure to cigarette smoke, patchy emphysema was present in mice of both strains, but developed faster in DBA/2 mice. A positive reaction for mouse neutrophil elastase was seen on the septa of both strains. Additionally, the DBA/2 mice developed a uniform parenchymal dilation that was preceded by the appearance of apoptotic cells in areas with a low signal for vascular endothelial growth factor-receptor 2. Fibrotic areas scattered throughout the parenchyma, coupled with a positive immunohistochemical reaction for transforming growth factor-beta was seen only in DBA/2 mice. Both DBA/2 and C57Bl/6J strains showed epithelial cell injury and areas of deciliation in their airways. However, the appearance of goblet cell metaplasia was common in C57Bl/6J mice but rare in DBA/2 mice. A positive immunohistochemical reaction for interleukin (IL)-4, IL-13 and MUC5AC was seen only in the airways of C57Bl/6J mice. Strain characteristics (alpha1-proteinase inhibitor levels, sensitivity to oxidants, and constitutive levels of vascular endothelial growth factor-receptor 2) and phenotypical responses (apoptosis and cytokine distribution) may condition parenchymal and airway changes to cigarette smoke.


Subject(s)
Oxidants/pharmacology , Pulmonary Emphysema/diagnostic imaging , Pulmonary Emphysema/pathology , Tobacco Smoke Pollution/adverse effects , Analysis of Variance , Animals , Disease Models, Animal , Immunohistochemistry , In Situ Nick-End Labeling , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Microscopy/methods , Probability , Risk Factors , Severity of Illness Index , Species Specificity , Ultrasonography
4.
Eur Respir J ; 22(5): 728-34, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14621076

ABSTRACT

Under steady state conditions the intracellular pathway is the major route of collagen catabolism in tissues characterised by rapid collagen turnover. In the lung, the collagen is subject to continuous remodelling and turnover however, the intracellular pathway of collagen degradation is unusual under physiological conditions. The current authors previously described crystalloid inclusions in alveolar macrophages of mice with genetic emphysema at the time of septal disruption. Using an immunogold technique these inclusions were identified as collagen-derived products and related to intracytoplasmic collagen degradation. To examine whether a different degree of protease burden in lung interstitium may influence the route of intracellular collagen degradation, collagen phagocytosis by alveolar macrophages was studied in various mouse models of emphysema at the time when emphysema develops. Evident collagen by-products in alveolar macrophages were observed in destructive processes characterising spontaneous models of emphysema either with negligible (blotchy mouse) or moderate (pallid mouse) elastase burden. On the other hand, intracellular collagen by-products were appreciated only in a few macrophages from tight-skin mice with high elastolytic burden and could not be observed in mice with a very severe burden after elastase instillation. In conclusion, the interstitial level of proteases burden can affect the way by which the collagen is cleared (intracellularly versus extracellularly).


Subject(s)
Collagen/metabolism , Macrophages, Alveolar/physiology , Phagocytosis , Pulmonary Emphysema/physiopathology , Animals , Bronchoalveolar Lavage Fluid/chemistry , Crystalloid Solutions , Immunohistochemistry , Inclusion Bodies/ultrastructure , Isotonic Solutions , Macrophages, Alveolar/metabolism , Macrophages, Alveolar/ultrastructure , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Pancreatic Elastase/analysis , Plasma Substitutes/analysis , Pulmonary Emphysema/metabolism , Pulmonary Emphysema/pathology
5.
Am J Respir Crit Care Med ; 164(5): 886-90, 2001 Sep 01.
Article in English | MEDLINE | ID: mdl-11549550

ABSTRACT

The role of strain difference in the response to cigarette smoke was investigated in mice. Mice of the strains DBA/2 and C57BL/6J responded to acute cigarette smoke with a decrease of the antioxidant defenses of their bronchoalveolar lavage (BAL) fluids. On the other hand, under these conditions ICR mice increased their BAL antioxidant defenses. Mice of these three strains were then exposed to cigarette smoke (three cigarettes/d, 5 d/wk) for 7 mo. Lung elastin content was significantly decreased in C57BL/6J and DBA/2 but not in ICR mice. Also, emphysema, assessed morphometrically using three methods, was present in C57BL/6J and DBA/2 but not in ICR mice. In an additional study pallid mice, with a severe serum alpha(1)-proteinase inhibitor (alpha(1)-PI) deficiency and that develop spontaneous emphysema, were exposed to cigarette smoke for 4 mo. This resulted in an acceleration of the development of the spontaneous emphysema assessed with morphometrical and biochemical (lung elastin content) methods. All these results indicate that sensitivity to the effects of cigarette smoke is strain-dependent and cigarette smoke accelerates the effects of alpha(1)-PI deficiency.


Subject(s)
Nicotiana , Smoke , alpha 1-Antitrypsin/administration & dosage , Animals , Antioxidants/administration & dosage , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Inbred ICR
6.
Am J Physiol Lung Cell Mol Physiol ; 281(2): L412-7, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11435216

ABSTRACT

The role of oxidative stress in inactivating antiproteases is the object of debate. To address this question, we developed an in vivo model of pulmonary oxidative stress induced by cigarette smoke (CS) in mice. The major mouse trypsin inhibitor contrapsin is not sensitive to oxidation, and the mouse secretory leukoprotease inhibitor (SLPI) does not inhibit trypsin. Instead, human recombinant (hr) SLPI inhibits trypsin and is sensitive to oxidation. Thus we determined the effect of CS in vivo on hrSLPI antiproteolytic function in the airways of mice. CS caused a significant decrease in total antioxidant capacity in bronchoalveolar lavage fluid (BALF) and significant changes in oxidized glutathione, ascorbic acid, protein thiols, and 8-epi-PGF(2alpha). Intratracheal hrSLPI significantly increased BALF antitryptic activity. CS induced a 50% drop in the inhibitory activity of hrSLPI. Pretreatment with N-acetylcysteine prevented the CS-induced loss of hrSLPI activity, the decrease in antioxidant defenses, and the elevation of 8-epi-PGF-(2alpha). Thus an inactivation of hrSLPI was demonstrated in this model. This is a novel model for studying in vivo the effects of CS oxidative stress on human protease inhibitors with antitrypsin activity.


Subject(s)
Environmental Exposure , Lung/metabolism , Nicotiana , Oxidative Stress/physiology , Plants, Toxic , Proteins/physiology , Serpins , Smoke , Acetylcysteine/pharmacology , Animals , Bronchoalveolar Lavage Fluid/chemistry , Free Radical Scavengers/pharmacology , Humans , Male , Mice , Mice, Inbred C57BL , Proteinase Inhibitory Proteins, Secretory , Proteins/metabolism , Recombinant Proteins , Secretory Leukocyte Peptidase Inhibitor , Trypsin Inhibitors/analysis
7.
Eur Respir J ; 17(3): 474-80, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11405528

ABSTRACT

It has recently been suggested that proteinase inhibitors modulate the fibrotic response in the lung. This study investigated the development of bleomycin-induced pulmonary changes in pallid mice, deficient in serum alpha1-proteinase inhibitor, and with a lower elastase inhibitory capacity, and in congenic C57Bl/6J mice. Male pallid and C57Bl/6J mice received a single intratracheal instillation of either saline or bleomycin. The investigation was carried out by means of biochemical, morphological and morphometrical methods. In both strains, 21 and 72 h after bleomycin, the lungs showed foci of inflammatory cell infiltration associated with emphysema. Fibrosis developed with time after bleomycin. At 14 days fibrosis affected 23.46+/-9.48% (mean +/- SD) and 40.62+/-13.34% (p < 0.01) of the lungs of C57Bl/6J and pallid mice, respectively. Emphysema affected 3.68+/-3.11% and 12.57+/-4.13% (p<0.01) of lung in C57Bl/6J and pallid mice, respectively. In C57Bl/6J mice bleomycin increased lung hydroxyproline content by 34% and desmosine content by 44% (p < 0.01 for both). In pallid mice these increases were only 21% (p < 0.01) and 6% which may reflect parenchymal loss. Thus, the lung destructive response (emphysema) and the subsequent proliferative reaction (fibrosis) to bleomycin are potentiated in alpha1-proteinase inhibitor deficiency.


Subject(s)
Anti-Bacterial Agents/adverse effects , Bleomycin/adverse effects , Lung/drug effects , Lung/pathology , alpha 1-Antitrypsin/genetics , Animals , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL
8.
J Histochem Cytochem ; 48(9): 1233-42, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10950880

ABSTRACT

To elucidate the role of intermediate filament proteins in endocrine cells, we investigated the expression and subcellular distribution of GFAP in mouse islets of Langerhans. For this purpose, combined immunocytochemical and biochemical analysis with a panel of antibodies was carried out to identify GFAP-immunoreactive cells in mouse endocrine pancreas. Cell fractionation into NP-40-soluble and detergent/high salt-insoluble components was performed to assess whether GFAP was located in the cytosolic and/or cytoskeletal compartments of immunoreactive cells. Immunoelectron microscopic analysis was carried out to determine the subcellular distribution of the protein. Peripheral islet cells were stained with anti-GFAP antiserum. These cells were identified as glucagon-secreting cells by immunocytochemical staining of consecutive sections with anti-somatostatin, anti-GFAP, and anti-glucagon antisera. Western blotting analysis of both NP-40-soluble and detergent/high-salt insoluble fractions of isolated islets of Langerhans allowed detection of GFAP in both cytosolic and cytoskeletal compartments. Interestingly, however, the former location was highly predominant. In addition, immunoelectron microscopy localized GFAP associated with the periphery of secretory granules. On the basis of these results, an intriguing role for GFAP in secretory events should be strongly suspected.(J Histochem Cytochem 48:1233-1242, 2000)


Subject(s)
Cytoplasmic Granules/metabolism , Glial Fibrillary Acidic Protein/metabolism , Glucagon/metabolism , Islets of Langerhans/metabolism , Animals , Blotting, Western , Cell Fractionation , Immunohistochemistry , Islets of Langerhans/cytology , Islets of Langerhans/ultrastructure , Male , Mice , Microscopy, Immunoelectron , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...